Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4120655
Reference Type
Journal Article
Title
Ocular bioavailability of topical prednisolone preparations
Author(s)
Olejnik, O; Weisbecker, CA
Year
1990
Is Peer Reviewed?
Yes
Journal
Clinical Therapeutics
ISSN:
0149-2918
Report Number
IPA/90/918176
Volume
Ther
Issue
REF 27
Page Numbers
2-11
Language
English
Abstract
IPA COPYRIGHT: ASHP Research on the anti-inflammatory effects of prednisolone sodium phosphate (I) ophthalmic solution and prednisolone acetate (II) ophthalmic suspension is reviewed critically and methodological problems in the study of ocular drugs are identified. A pharmacokinetic model of the absorption of water-insoluble drugs (such as II) and water-soluble drugs (such as I) including drug elimination and dissolution, rates of drug penetration and transport is presented; both drugs have moderate to high anti-inflammatory effects. It is concluded that even though anti-inflammatory effects are similar, a solution of I is preferable to a suspension of II due to the possibilities of poor particle distribution leading to incorrect dosing.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity